 |
Abdom Radiol (NY)
- HU X, Wang K, Sun M, Li C, et al
Quantitative MRI in distinguishing bladder paraganglioma from bladder leiomyoma.
Abdom Radiol (NY). 2023;48:1051-1061.
PubMed
Abstract available
Acta Chir Belg
- BORET S, Lambert E, Charles VP, Philippe T, et al
Vulvar pagetoid urothelial intraepithelial neoplasia: a case report.
Acta Chir Belg. 2023;123:174-177.
PubMed
Abstract available
Actas Urol Esp (Engl Ed)
- GUERRERO-RAMOS F
BCG unresponsive non-muscle invasive bladder cancer: The beginning of a new era?
Actas Urol Esp (Engl Ed). 2023 Feb 24:S2173-5786(23)00018.
PubMed
Ann Diagn Pathol
- SYED M, Mushtaq S, Loya A, Hassan U, et al
Prognostic significance of minor high grade component in non-invasive papillary
urothelial carcinoma of urinary bladder: (A study of 273 consecutive cases over a
period of 3 years).
Ann Diagn Pathol. 2023;63:152079.
PubMed
Abstract available
- BABAN F, Auen T, Eschbacher KL, Swanson AA, et al
Invasive urothelial carcinoma with squamous differentiation and associated
high-risk human papilloma virus infection: Clinical, cytologic, and histologic
features of a rare entity.
Ann Diagn Pathol. 2023;63:152103.
PubMed
Abstract available
- PEREZ-MONTIEL D, Olivares-Mundo A, Jimenez-Rios MA, Morera CS, et al
Influence of luminal and basal subtype in prognosis of high-grade non muscle
invasive urothelial carcinoma.
Ann Diagn Pathol. 2023;63:152081.
PubMed
Abstract available
Ann Med
- YU Z, Lu C, Lai Y
A serum miRNAs signature for early diagnosis of bladder cancer.
Ann Med. 2023;55:736-745.
PubMed
Abstract available
Ann Oncol
- BALAR AV, Castellano DE, Grivas P, Vaughn DJ, et al
Efficacy and safety of pembrolizumab in metastatic urothelial carcinoma: results
from KEYNOTE-045 and KEYNOTE-052 after up to 5 years of follow-up.
Ann Oncol. 2023;34:289-299.
PubMed
Abstract available
Anticancer Res
- LI JR, Wang SS, Lu K, Chen CS, et al
First-line Chemotherapy Response Is Associated With Clinical Outcome During
Immune Checkpoint Inhibitor Treatment in Advanced Urothelial Carcinoma: A Real
World Retrospective Study.
Anticancer Res. 2023;43:1331-1339.
PubMed
Abstract available
- CHEN SY, Chao CN, Huang HY, Zhao PW, et al
Artesunate Exhibits Synergy With Cisplatin and Cytotoxicity for Upper Tract and
Bladder Urothelial Carcinoma Cells.
Anticancer Res. 2023;43:1175-1184.
PubMed
Abstract available
Antioxidants (Basel)
- GALINIAK S, Molon M, Biesiadecki M, Mokrzynska A, et al
Oxidative Stress Markers in Urine and Serum of Patients with Bladder Cancer.
Antioxidants (Basel). 2023;12:277.
PubMed
Abstract available
ANZ J Surg
- CHAU M, Thia I, Viswambaram P, Hawks C, et al
Lymph node assessment technique matters in radical cystectomy for bladder cancer.
ANZ J Surg. 2023 Mar 3. doi: 10.1111/ans.18292.
PubMed
Abstract available
Asian Pac J Cancer Prev
- YOUSSIEF MOHAMMED AA, Gamal DA, Abd Elzaher AR, Hasaballah A, et al
Trimodality Therapy in which Concurrent Chemoradiation with Concomitant Boost in
Muscle Invasive TCC Urinary Bladder Cancer.
Asian Pac J Cancer Prev. 2023;24:517-524.
PubMed
Abstract available
Biomedicines
- JAIN M, Tivtikyan A, Kamalov D, Avdonin S, et al
Development of a Sensitive Digital Droplet PCR Screening Assay for the Detection
of GPR126 Non-Coding Mutations in Bladder Cancer Urine Liquid Biopsies.
Biomedicines. 2023;11:495.
PubMed
Abstract available
- SHI Y, Mathis BJ, He Y, Yang X, et al
The Current Progress and Future Options of Multiple Therapy and Potential
Biomarkers for Muscle-Invasive Bladder Cancer.
Biomedicines. 2023;11:539.
PubMed
Abstract available
Biosci Rep
-
Retraction: CircRNA circPDSS1 promotes bladder cancer by downregulating miR-16.
Biosci Rep. 2023;43:BSR-2019-1961.
PubMed
BJU Int
- NURMINEN P, Ettala O, Uusitalo-Seppala R, Hogerman M, et al
Clinical presentation of bacille Calmette-Guerin (BCG) infections after BCG
instillation therapy.
BJU Int. 2023;131:306-312.
PubMed
Abstract available
BMC Urol
- LI X, Fu C, Li G, He H, et al
RNA-seq reveals novel mechanistic targets of Livin in bladder cancer.
BMC Urol. 2023;23:26.
PubMed
Abstract available
Br J Cancer
- VASDEV N
Multicentric validation of nomograms based on BC-116 and BC-106 urine peptide
biomarker panels for bladder cancer diagnostics and monitoring in two prospective
cohorts of patients.
Br J Cancer. 2023 Mar 1. doi: 10.1038/s41416-023-02142.
PubMed
Cancer Immunol Immunother
- SONPAVDE GP, Maughan BL, McGregor BA, Wei XX, et al
Phase II trial of CV301 vaccine combined with atezolizumab in advanced urothelial
carcinoma.
Cancer Immunol Immunother. 2023;72:775-782.
PubMed
Abstract available
Cancer Med
- ITO K, Kita Y, Yokomizo A, Miki J, et al
Discontinuation of pembrolizumab for advanced urothelial carcinoma without
disease progression: Nationwide cohort study.
Cancer Med. 2023;12:2325-2332.
PubMed
Abstract available
- WU Y, Zhu W, Wang J, Liu L, et al
Using machine learning for mortality prediction and risk stratification in
atezolizumab-treated cancer patients: Integrative analysis of eight clinical
trials.
Cancer Med. 2023;12:3744-3757.
PubMed
Abstract available
- HUANG J, Huang D, Ruan X, Huang J, et al
Association between cannabis use with urological cancers: A population-based
cohort study and a mendelian randomization study in the UK biobank.
Cancer Med. 2023;12:3468-3476.
PubMed
Abstract available
- MATSUBARA N, Yonese J, Kojima T, Azuma H, et al
Japanese subgroup analysis of EV-301: An open-label, randomized phase 3 study to
evaluate enfortumab vedotin versus chemotherapy in subjects with previously
treated locally advanced or metastatic urothelial carcinoma.
Cancer Med. 2023;12:2761-2771.
PubMed
Abstract available
- LIMONNIK V, Samiei A, Abel S, Wegner RE, et al
Urachal carcinoma: A novel staging system utilizing the National Cancer Database.
Cancer Med. 2023;12:2752-2760.
PubMed
Abstract available
- ALRADHI M, Wen S, Safi M, Al-Danakh A, et al
Molecular genetic and clinical characteristic analysis of primary signet ring
cell carcinoma of urinary bladder identified by a novel OR2L5 mutation.
Cancer Med. 2023;12:3931-3951.
PubMed
Abstract available
Cancers (Basel)
- ABOUDARAM A, Chaltiel L, Pouessel D, Graff-Cailleaud P, et al
Consolidative Radiotherapy for Metastatic Urothelial Bladder Cancer Patients with
No Progression and with No More than Five Residual Metastatic Lesions Following
First-Line Systemic Therapy: A Retrospective Analysis.
Cancers (Basel). 2023;15:1161.
PubMed
Abstract available
- LEE HW, Kwon WA, Nguyen NT, Phan DTT, et al
Approaches to Clinical Complete Response after Neoadjuvant Chemotherapy in
Muscle-Invasive Bladder Cancer: Possibilities and Limitations.
Cancers (Basel). 2023;15:1323.
PubMed
Abstract available
- LEE MC, Wang SY, Pan CT, Chien MY, et al
Development of Deep Learning with RDA U-Net Network for Bladder Cancer
Segmentation.
Cancers (Basel). 2023;15:1343.
PubMed
Abstract available
- LIN PT, Hung WK, Chang YH, Hsieh ML, et al
Replacement Instead of Discontinuation of Bacillus Calmette-Guerin Instillation
in Non-Muscle-Invasive Bladder Cancer.
Cancers (Basel). 2023;15:1345.
PubMed
Abstract available
- GAO Y, Cao H, Huang D, Zheng L, et al
RNA-Binding Proteins in Bladder Cancer.
Cancers (Basel). 2023;15:1150.
PubMed
Abstract available
- WANG H, Feng Y, Zheng X, Xu X, et al
The Diagnostic and Therapeutic Role of snoRNA and lincRNA in Bladder Cancer.
Cancers (Basel). 2023;15:1007.
PubMed
Abstract available
Cells
- KOLL FJ, Metzger E, Hamann J, Ramos-Triguero A, et al
Overexpression of KMT9alpha Is Associated with Aggressive Basal-like Muscle-Invasive
Bladder Cancer.
Cells. 2023;12:589.
PubMed
Abstract available
Clin Transl Med
- XU H, Liu Z, Weng S, Ren Y, et al
Epigenetically regulated gene expression profiles recognized three molecular
classifications with prognostic and therapeutic implications in bladder cancer.
Clin Transl Med. 2023;13:e1145.
PubMed
Clin Transl Oncol
- BOROWCZAK J, Szczerbowski K, Maniewski M, Zdrenka M, et al
The prognostic role of p53 and its correlation with CDK9 in urothelial carcinoma.
Clin Transl Oncol. 2023;25:830-840.
PubMed
Abstract available
Comb Chem High Throughput Screen
- WANG W, Chen L, Yang J, Hu D, et al
Apatinib Inhibits Bladder Cancer through Suppression of The VEGFR2-PI3K-AKT
Signaling Pathway as revealed by Network Pharmacology and In Vitro Experimental
Verification.
Comb Chem High Throughput Screen. 2023.
PubMed
Abstract available
Commun Biol
- MARTINEZ-VIDAL L, Chighizola M, Berardi M, Alchera E, et al
Micro-mechanical fingerprints of the rat bladder change in actinic cystitis and
tumor presence.
Commun Biol. 2023;6:217.
PubMed
Abstract available
Curr Oncol Rep
- BOULEFTOUR W, Sargos P, Magne N
Nectin-4: a Tumor Cell Target and Status of Inhibitor Development.
Curr Oncol Rep. 2023;25:181-188.
PubMed
Abstract available
Endocr Metab Immune Disord Drug Targets
- FENG R, Li Z, Ge G, Wang C, et al
Cancer-associated fibroblast-derived extracellular vesicles mediate immune escape
of bladder cancer via PD-L1/PD-1 expression.
Endocr Metab Immune Disord Drug Targets. 2023.
PubMed
Abstract available
Epidemiol Prev
- ZONA A, Fazzo L, Benedetti M, Bruno C, et al
[SENTIERI - Epidemiological Study of Residents in National Priority Contaminated
Sites. Sixth Report].
Epidemiol Prev. 2023;47.
PubMed
Abstract available
Eur J Surg Oncol
- MOEEN AM, Behnsawy HM, Faragallah MA, Gadelkareem RA, et al
Functional evaluation of a spiral neobladder with an angled chimney; A
prospective randomized comparative study.
Eur J Surg Oncol. 2023;49:491-496.
PubMed
Abstract available
Eur Urol
- SYLVESTER RJ, Rodriguez O, Hernandez V, Turturica D, et al
Erratum to "European Association of Urology (EAU) Prognostic Factor Risk Groups
for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016
and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC
Guidelines Panel
Eur Urol. 2023 Feb 23:S0302-2838(23)02579-4. doi: 10.1016/j.eururo.2023.
PubMed
- STENZL A, Roupret M, Witjes JA, Gontero P, et al
High-quality Transurethral Resection of Bladder Tumour Needs Additional Forms of
Tumour Delineation.
Eur Urol. 2023;83:193-194.
PubMed
Abstract available
Front Immunol
- TANG Q, Zuo W, Wan C, Xiong S, et al
Comprehensive genomic profiling of upper tract urothelial carcinoma and
urothelial carcinoma of the bladder identifies distinct molecular
characterizations with potential implications for targeted therapy &
immunotherapy.
Front Immunol. 2023;13:1097730.
PubMed
Abstract available
Front Oncol
- WOLF P
Inhibitor of apoptosis proteins as therapeutic targets in bladder cancer.
Front Oncol. 2023;13:1124600.
PubMed
Abstract available
Genet Test Mol Biomarkers
- WANG XF, Liu DL, Geng L
The PSCA rs2294008 (C/T) Polymorphism Increases the Risk of Gastric and Bladder
Cancer: A Meta-Analysis.
Genet Test Mol Biomarkers. 2023;27:44-55.
PubMed
Abstract available
Georgian Med News
- IMAMVERDIYEV S, Qasimov E, Naghiyev R
COMPARATIVE RESULTS OF MODERN EXAMINATION METHODS IN EARLY DIAGNOSIS OF BLADDER
CANCER, DETERMINATION OF THE DEGREE OF INVASION AND SELECTION OF RADICAL
TREATMENT TACTICS.
Georgian Med News. 2023;:98-102.
PubMed
Abstract available
Hinyokika Kiyo
- IKEDA M, Uemura K, Araki Y, Iribe Y, et al
[A Case of Long-Term Survival Following Multidisciplinary Therapy for Small
Intestinal Metastasis of Bladder Cancer].
Hinyokika Kiyo. 2023;69:55-58.
PubMed
Abstract available
IET Syst Biol
- LI SH, Zhai GQ, He RQ, Chen G, et al
Down-regulation and clinical significance of Sorbin and SH3 domain-containing
protein 1 in bladder cancer tissues.
IET Syst Biol. 2023 Feb 28. doi: 10.1049/syb2.12060.
PubMed
Abstract available
Indian J Cancer
- TACAR SY, Yilmaz M, Baytekin HF, Tural D, et al
Evaluation of predictive factors in patients with bladder cancer undergoing
atezolizumab treatment: Case reports.
Indian J Cancer. 2022;59:556-559.
PubMed
Abstract available
Int J Mol Sci
- YANG CC, Chuang FC, Chang CL, Huang CR, et al
Melatonin-Assisted Cisplatin Suppresses Urinary Bladder Cancer Cell Proliferation
and Growth through Inhibiting PrP(C)-Regulated Cell Stress and Cell Proliferation
Signaling.
Int J Mol Sci. 2023;24:3353.
PubMed
Abstract available
- BOSCHI F, Malatesta M
Nanoparticle-Based Techniques for Bladder Cancer Imaging: A Review.
Int J Mol Sci. 2023;24:3812.
PubMed
Abstract available
- SANGUEDOLCE F, Zanelli M, Palicelli A, Bisagni A, et al
HER2 Expression in Bladder Cancer: A Focused View on Its Diagnostic, Prognostic,
and Predictive Role.
Int J Mol Sci. 2023;24:3720.
PubMed
Abstract available
Int Urol Nephrol
- QIU Y, Zhang X, Dong Z, Zhang Y, et al
Comparable survival benefits of partial ureterectomy to radical
nephroureterectomy in non-metastatic ureter carcinoma: a population-matched
study.
Int Urol Nephrol. 2023;55:579-588.
PubMed
Abstract available
- DEWITT-FOY ME, Anele UA, Accioly JPE, Sharpe MG, et al
Cancer risk in bladder diverticula: a large institutional analysis of risk and
management.
Int Urol Nephrol. 2023;55:541-546.
PubMed
Abstract available
J Clin Med
- LEMINSKI A, Michalski W, Masojc B, Kaczmarek K, et al
Combined Modality Bladder-Sparing Therapy for Muscle-Invasive Bladder Cancer: How
(Should) We Do It? A Narrative Review.
J Clin Med. 2023;12:1560.
PubMed
Abstract available
- WEN P, Wen J, Huang X, Wang F, et al
Development and Validation of Nomograms Predicting the 5- and 8-Year Overall and
Cancer-Specific Survival of Bladder Cancer Patients Based on SEER Program.
J Clin Med. 2023;12:1314.
PubMed
Abstract available
J Immunother Cancer
- JOSHI M, Tuanquin L, Zhu J, Walter V, et al
Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant
durvalumab in patients with localized urothelial cancer of bladder: results from
phase II study, BTCRC-GU15-023.
J Immunother Cancer. 2023;11:e006551.
PubMed
Abstract available
JAMA Netw Open
- MCELREE IM, Steinberg RL, Mott SL, O'Donnell MA, et al
Comparison of Sequential Intravesical Gemcitabine and Docetaxel vs Bacillus
Calmette-Guerin for the Treatment of Patients With High-Risk Non-Muscle-Invasive
Bladder Cancer.
JAMA Netw Open. 2023;6:e230849.
PubMed
Abstract available
JCO Precis Oncol
- KERIOUI M, Bertrand J, Desmee S, Le Tourneau C, et al
Assessing the Increased Variability in Individual Lesion Kinetics During
Immunotherapy: Does It Exist, and Does It Matter?
JCO Precis Oncol. 2023;7:e2200368.
PubMed
Abstract available
Molecules
- LIU Z, Song L, Xie J, Wu XR, et al
Kavalactone Kawain Impedes Urothelial Tumorigenesis in UPII-Mutant Ha-Ras Mice
via Inhibition of mTOR Signaling and Alteration of Cancer Metabolism.
Molecules. 2023;28:1666.
PubMed
Abstract available
Pan Afr Med J
- MAJA SG, Slavica KK, Suad A, Rubens J, et al
Bladder mucinous adenocarcinoma as a diagnostic challenge: a case report.
Pan Afr Med J. 2022;42:221.
PubMed
Abstract available
Pathol Oncol Res
- WANG Z, Wang J, Zhang W, Wang D, et al
Case report: Urothelial carcinoma of the renal pelvis with trophoblastic
differentiation: A rare case report and review of literature.
Pathol Oncol Res. 2023;29:1610856.
PubMed
Abstract available
Pathologica
- RASPOLLINI MR, Comperat EM, Lopez-Beltran A, Montironi R, et al
News in the classification of WHO 2022 bladder tumors.
Pathologica. 2022;115:32-40.
PubMed
Abstract available
Pediatr Blood Cancer
- FUJIKI T, Sakai Y, Ikawa Y, Takenaka M, et al
Pediatric inflammatory myofibroblastic tumor of the bladder with ALK-FN1 fusion
successfully treated by alectinib.
Pediatr Blood Cancer. 2023;70:e30172.
PubMed
Abstract available
Plant Foods Hum Nutr
- ALTIERI MA, Sarmiento-Machado LM, Romualdo GR, de Moura NA, et al
Dietary Capsaicin Reduces Chemically Induced Rat Urinary Bladder Carcinogenesis.
Plant Foods Hum Nutr. 2023;78:93-99.
PubMed
Abstract available
PLoS One
- WEINBERG L, Aitken SAA, Kaldas P, Fletcher L, et al
Postoperative complications and hospital costs following open radical cystectomy:
A retrospective study.
PLoS One. 2023;18:e0282324.
PubMed
Abstract available
Pol Arch Intern Med
- BALAWENDER K, Wawrzyniak A, Walocha J, Mazur M, et al
Leiomyoma: a case of a rare benign mesenchymal neoplasm of the urinary bladder.
Pol Arch Intern Med. 2023;133:16381.
PubMed
Radiother Oncol
- DE HAAR-HOLLEMAN A, van Hoogstraten LMC, C C M Hulshof M, Tascilar M, et al
Chemoradiation for muscle-invasive bladder cancer using 5-fluorouracil versus
capecitabine: a nationwide cohort study.
Radiother Oncol. 2023 Feb 28:109584. doi: 10.1016/j.radonc.2023.109584.
PubMed
Abstract available
Retin Cases Brief Rep
- LENTZSCH AM, Siggel R, Schnorr C, Holtick U, et al
LONG-TERM FOLLOW-UP OF ASYMMETRIC BILATERAL DIFFUSE UVEAL MELANOCYTIC
PROLIFERATION IN A PATIENT WITH METASTASIZED UROTHELIAL CARCINOMA.
Retin Cases Brief Rep. 2023;17:105-110.
PubMed
Abstract available
Scand J Urol
- KARTTUNEN E, Hervonen P, Hosseini Aliabad A, Oldenburg J, et al
Incidence, mortality and relative survival of patients with cancer of the bladder
and upper urothelial tract in the Nordic countries between 1990 and 2019.
Scand J Urol. 2023;57.
PubMed
Abstract available
- BREHMER M
Register-based research. Accurate data and analysis, crucial for correct
conclusions. Comment on "Incidence, mortality, and relative survival of patients
with cancer of the bladder and upper urothelial tract in the Nordic countries
between 1990 and 20
Scand J Urol. 2023;57.
PubMed
Sci Adv
- AN HW, Hou DY, Yang J, Wang ZQ, et al
A bispecific glycopeptide spatiotemporally regulates tumor microenvironment for
inhibiting bladder cancer recurrence.
Sci Adv. 2023;9:eabq8225.
PubMed
Abstract available
Technol Cancer Res Treat
- MAZZASCHI G, Giudice GC, Coriano M, Campobasso D, et al
Upper Tract Urinary Carcinoma: A Unique Immuno-Molecular Entity and a Clinical
Challenge in the Current Therapeutic Scenario.
Technol Cancer Res Treat. 2023;22:15330338231159753.
PubMed
Abstract available
Tohoku J Exp Med
- GAO S, Zhou XQ, Wu Q, Chen XD, et al
Effects of Holliday Junction-Recognition Protein-Mediated C-Jun N-Terminal
Kinase/ Signal Transducer and Activator of Transcription 3 Signaling Pathway on
Cell Proliferation, Cell Cycle and Cell Apoptosis in Bladder Urothelial
Carcinoma.
Tohoku J Exp Med. 2023;259:209-219.
PubMed
Abstract available
Urol Case Rep
- KOKURA K, Watanabe J, Takuma T, Uketa S, et al
A case of Avelumab response to multiple bone and lymph node metastases of
plasmacytoid variant bladder cancer.
Urol Case Rep. 2023;47:102358.
PubMed
Abstract available
Urol Oncol
- LIU Y, Zhao YC, Lu Y, Goodarz D, et al
The role of smoking in explaining racial/ethnic disparities in bladder cancer
incidence in the United States.
Urol Oncol. 2023 Feb 25:S1078-1439(23)00051.
PubMed
Abstract available
Urologia
- GUPTA P, Sarangi SS, Singh M, Pandey H, et al
To determine correlation between VIRADS scoring and pathological staging in
bladder cancer: A prospective study and review of literature.
Urologia. 2023 Feb 27:3915603231151738. doi: 10.1177/03915603231151738.
PubMed
Abstract available
World J Surg Oncol
- HE HL, Lai HY, Chan TC, Hsing CH, et al
Low expression of ZSCAN4 predicts unfavorable outcome in urothelial carcinoma of
upper urinary tract and urinary bladder.
World J Surg Oncol. 2023;21:62.
PubMed
Abstract available
- CINAR NB, Yilmaz H, Avci IE, Cakmak K, et al
Reporting perioperative complications of radical cystectomy: the influence of
using standard methodology based on ICARUS and EAU quality criteria.
World J Surg Oncol. 2023;21:58.
PubMed
Abstract available
World J Urol
- HEKMAN MCH, Wijn SRW, Lotan Y, Govers TM, et al
Bladder EpiCheck urine test in the follow-up of NMIBC: a cost analysis.
World J Urol. 2023;41:471-476.
PubMed
Abstract available
- DUQUESNE I, Benamran D, Masson-Lecomte A, De La Taille A, et al
Intraoperative complication of radical cystectomy for muscle-invasive bladder
cancer: does the surgical approach matter? A retrospective multicenter study
using the EAUiaiC classification.
World J Urol. 2023 Feb 27. doi: 10.1007/s00345-023-04340.
PubMed
Abstract available
- PETEINARIS A, Kallidonis P, Tsaturyan A, Pagonis K, et al
The feasibility of robot-assisted radical cystectomy: an experimental study.
World J Urol. 2023;41:477-482.
PubMed
Abstract available
- FRANCO N, Godono A, Clari M, Ciocan C, et al
Occupational asbestos exposure and urinary bladder cancer: a systematic review
and meta-analysis.
World J Urol. 2023 Feb 27. doi: 10.1007/s00345-023-04327.
PubMed
Abstract available
|
AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to
a media sponsorship by
Boehringer Ingelheim.
Design:
|
FAQ